title: Successful use of adalimumab in treating cutaneous metastatic Crohn's disease: report of a case.
authors.forename: Faith A
authors.initials: FA
authors.lastname: Miller
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Jones
authors.forename: Loren E
authors.initials: LE
authors.lastname: Clarke
authors.forename: Zenwu
authors.initials: Z
authors.lastname: Lin
authors.forename: David R
authors.initials: DR
authors.lastname: Adams
authors.forename: Walter A
authors.initials: WA
authors.lastname: Koltun
mesh_terms: D000068879:Adalimumab; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D003424:Crohn Disease / Q000150:complications*; D005260:Female; D006099:Granuloma / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D008875:Middle Aged; D012871:Skin Diseases / Q000188:drug therapy* / Q000209:etiology*; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068879:Adalimumab